Table 1.
Baseline characteristics (n=64)
| Treatment status | ||||
|---|---|---|---|---|
| Variable | Total | Active treatment | Surveillance | P 1 |
| Gender, N (%) | ||||
| Female | 29 (45.3) | 6 (60.0) | 23 (42.6) | 0.4910[F] |
| Male | 35 (54.7) | 4 (40.0) | 31 (57.4) | |
| Age, Mean (SD) | 60.84 (10.38) | 60.70 (11.97) | 60.87 (10.17) | 0.9636[T] |
| Race, N (%) | ||||
| Other | 2 (3.1) | 0 (0.0) | 2 (3.7) | 1.0000[F] |
| White | 62 (96.9) | 10 (100) | 52 (96.3) | |
| Ethnicity, N (%) | ||||
| Latinx | 3 (4.7) | 1 (10.0) | 2 (3.7) | 0.4047[F] |
| non-Latinx | 61 (95.3) | 9 (90.0) | 52 (96.3) | |
| Partner status, N (%) | ||||
| Other | 12 (19.0) | 4 (40.0) | 8 (15.1) | 0.0862[F] |
| Married/partnered | 51 (81.0) | 6 (60.0) | 45 (84.9) | |
| Education, N (%) | ||||
| College degree or less | 28 (43.8) | 6 (60.0) | 22 (40.7) | 0.3116[F] |
| Post graduate | 36 (56.3) | 4 (40.0) | 32 (59.3) | |
| Cancer Type, N (%) | ||||
| CLL | 36 (59.0) | 4 (44.4) | 32 (61.5) | 0.4667[F] |
| Other | 25 (41.0) | 5 (55.6) | 20 (38.5) | |
| ECOG, N (%) | ||||
| 0 | 36 (60.0) | 3 (33.3) | 33 (64.7) | 0.1774[F] |
| 1 | 20 (33.3) | 5 (55.6) | 15 (29.4) | |
| 2 | 4 (6.7) | 1 (11.1) | 3 (5.9) | |
Note: This report only uses non-missing values in both variables (pairwise deletion) in the two-way table.
1
P values obtained from the statistical tests:
[F] –
Fisher’s exact test;
[T] -
T-test (equal variances)
*
P<.05;
**
P<.01.